GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dicot AB (XSAT:DICOT) » Definitions » Growth Rank

Dicot AB (XSAT:DICOT) Growth Rank : 0 (As of May. 22, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Dicot AB Growth Rank?

Dicot AB has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Dicot AB Growth Rank Related Terms

Thank you for viewing the detailed overview of Dicot AB's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Dicot AB (XSAT:DICOT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dicot AB (XSAT:DICOT) » Definitions » Growth Rank
Comparable Companies
XSAT:ODI OSTO:NANEXA OSTO:NEWBRY XSAT:PMED OSTO:KLAR OSTO:RLS OSTO:EMPLI OSTO:VIVE OSTO:GABA OSTO:ERMA ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
KN0:Germany
Address
Dag Hammarskjolds vag 30, Uppsala, SWE, SE 752 37
Website
http://www.dicot.se
Dicot AB is engaged in developing drugs against sexual dysfunction in Sweden. Its important products are Libiguin which is used for the treatment of erectile dysfunction and premature ejaculation in men, as well as potentially also for the treatment of decreased lust.

Dicot AB (XSAT:DICOT) Headlines

No Headlines